X0607 3 2026-09-29 0 0001833141 Helus Pharma Inc. HELP 0002116548 Cavers Greg true C/O HELUS PHARMA INC. 100 KING STREET W., SUITE 5600 TORONTO A6 M5X 1C9 ONTARIO, CANADA false true false false Chief Financial Officer Common Shares 125937 D Restricted Stock Units Common Shares 66668 D On October 1, 2025, the Reporting Person was granted 100,000 restricted stock units ("RSUs"), which vest as follows: 8,333 RSUs vesting on January 6, 2026, and 8,333 RSUs vesting quarterly over three years, on November 20, February 20, May 20 and August 20 until fully vested. As of the date of this Form 3, the Reporting Person holds 66,668 unvested RSUs from the October 2025 grant. Each RSU represents a contingent right to receive one Issuer common share. /s/ Greg Cavers 2026-10-01